Home › Funds › ASSOCIATED BANC-CORP › BSX

ASSOCIATED BANC-CORP position in BSX

BOSTON SCIENTIFIC CORP · Health Care

ASSOCIATED BANC-CORP reported holding 550,546 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$24.0M, representing 0.57% of its reported portfolio and ranking #50 among its reported holdings. ASSOCIATED BANC-CORP has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)550.55K sh
Reported value held$24.03M
Portfolio Weight0.57%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ASSOCIATED BANC-CORP's BSX position evolved

ASSOCIATED BANC-CORP first disclosed a stake in BSX in Q3 2023 at 430,188 shares (US$22.7M). The position peaked in Q2 2025 at 372,060 shares, worth US$40.0M. Across 13 filings, ASSOCIATED BANC-CORP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 550,546 shares valued at US$24.0M — a reduction of -20,845 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 430.19K $22.71M New
Q4 2023 429.00K $24.80M Hold
Q1 2024 437.11K $29.94M Add
Q2 2024 424.25K $32.67M Reduce
Q3 2024 422.71K $35.42M Hold
Q4 2024 423.25K $37.80M Hold
Q1 2025 374.88K $37.82M Reduce
Q2 2025 372.06K $39.96M Reduce
Q3 2025 372.44K $36.36M Hold
Q4 2025 373.83K $35.64M Hold
Q1 2026 480.36K $30.14M Add
Q2 2026 571.39K $24.39M Add
Q3 2026 550.55K $24.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has ASSOCIATED BANC-CORP held BSX?

ASSOCIATED BANC-CORP has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ASSOCIATED BANC-CORP's current position in BSX?

As of Q3 2026, ASSOCIATED BANC-CORP holds 550.55K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $24.03M, representing 0.57% of its reported portfolio and ranking #50.

Has ASSOCIATED BANC-CORP been buying or selling BSX?

In the latest 13F filing (Q3 2026), ASSOCIATED BANC-CORP reduced its position in BSX. The position peaked in Q2 2025 at 372.06K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.